查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1945112

全球醫藥包衣市場（按產品類型、聚合物類型、給藥途徑、應用和最終用戶分類）預測（2026-2032）

Pharmaceutical Coating Market by Product Type, Polymer Type, Route Of Administration, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 199 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，藥品塗層市場價值將達到 45 億美元，到 2026 年將成長至 48.1 億美元，到 2032 年將達到 71.9 億美元，複合年成長率為 6.92%。

關鍵市場統計數據
基準年 2025 45億美元
預計年份：2026年 48.1億美元
預測年份 2032 71.9億美元
複合年成長率 (%) 6.92%

本文簡要概述了藥物包衣的基本原理、市場促進因素、法規環境以及影響近期業務決策的策略重點。

藥物包衣領域是藥物製劑科學與商業產品供應的關鍵交會點，它整合了材料科學、法規遵循和生產實踐。本文概述了該領域的核心功能，重點闡述了包衣如何影響藥物的穩定性、生物利用度、患者接受度和供應鏈的穩健性。隨著產業的不斷發展，包覆的選擇對產品差異化和生命週期策略的影響日益顯著。因此，經營團隊必須了解製劑成分、生產限制和最終用戶期望之間的相互作用。

技術創新、永續性需求和供應鏈重組如何改變藥物包衣的配方和交付方式

技術進步、監管機構對品質源於設計 (QbD) 的重視以及相關人員對永續性的壓力，正共同推動藥物包衣配方和生產流程的變革。聚合物化學和包衣設備的進步使得對包衣厚度和釋放曲線的精確控制成為可能，而數位化監控和製程分析技術則為以往難以實現的大規模包衣製程帶來了一致性。同時，功能性包衣（例如緩釋和掩味系統）的創新，正在拓展配方選擇，並使產品團隊能夠以更低的風險追求差異化的給藥方案。

評估美國關稅和貿易政策變化在2025年對營運、定價和合規方面的累積影響

美國在2025年推出的政策轉變和關稅措施將對醫藥塗料價值鏈的投入成本、採購選擇和合約結構帶來特定壓力。不斷上升的關稅壁壘可能會增加進口聚合物和特殊添加劑的到岸成本，迫使採購團隊重新審視其供應商組合、重新談判合約條款並考慮近岸外包方案。為此，一些製造商可能會選擇增加庫存緩衝或優先簽訂長期供應協議，以穩定供應並降低價格波動。

按產品類型、聚合物化學、應用、給藥途徑和最終用戶管道細分細分市場層面的機會和績效指標

詳細的市場細分分析揭示了配方選擇、聚合物化學和終端用戶管道如何與生產限制和監管要求相互交織。按產品類型分類，市場分析涵蓋了壓片包衣、薄膜包衣、聚合物包衣和糖衣，每種產品路線都對製程控制和分析提出了獨特的要求。壓片包衣需要精確的片劑壓制和層間黏合力的控制，而薄膜包衣則強調聚合物分散的均勻性和塗覆過程中溶劑的處理。聚合物包衣具有可調的功能，但需要進行相容性測試，而糖衣是一種傳統的選擇，具有裝飾性和掩味作用。

美洲、歐洲、中東和非洲以及亞太市場存在明顯的區域策略差異和需求因素，這些差異和因素對業務營運產生影響。

區域趨勢對原料供應、法規要求和首選服務模式有顯著影響。在美洲，供應鏈韌性和監管協調工作往往側重於合規文件、本地品質審核，並優先考慮能夠展現快速反應能力的供應商。該地區通常需要可擴展的解決方案，並具備快速商業化週期和完善的監管路徑。

競爭動態、創新模式、夥伴關係模式和製造趨勢正在塑造製藥塗料行業的公司策略定位。

公司層面的策略呈現出圍繞著創新、整合和服務專業化的清晰差異化模式。主要企業正投資於配方科學、專有聚合物系統和自動化包衣平台，以縮短生產週期並提高產品可重複性。其他企業則透過契約製造客戶提供包括配方支援、製程驗證和供應鏈保障在內的綜合服務來實現差異化競爭。

為行業領導者提供可操作的優先事項和戰術性步驟，以增強韌性、加速創新並最佳化塗料價值鏈的採購。

產業領導者應立即採取切實可行的措施，增強韌性，加速創新，並最佳化整個塗料價值鏈的採購流程。首先，從配方開發的早期階段就整合跨職能團隊（包括採購、法規事務、研發和生產部門），確保材料選擇符合營運限制和核准途徑。這可以減少返工，加快產品上市速度，並從一開始就將品質因素納入考慮。其次，透過尋找替代供應商和製定策略性庫存政策，實現籌資策略多元化。嚴格的供應商審核和材料特性分析程序可以降低風險，減少供應中斷的可能性。

一種透明且可複製的調查方法，結合了初步訪談、技術文獻綜述、監管掃描和供應鏈檢驗技術。

本分析所依據的研究採用了混合方法，強調透明度、可重複性和實際相關性。主要研究包括與配方科學家、品管人員、採購經理和契約製造製造商進行結構化訪談和技術諮詢，以了解實際應用中的限制因素和決策標準。次要研究涵蓋了同行評審文獻、監管指導文件、安全資料表和設備技術規範，檢驗技術聲明並闡明製程要求。

本文簡要總結了戰略意義、新興風險和現有機遇，旨在為藥物包衣計畫的經營團隊重點提供參考。

總之，藥物包衣是一個具有重要策略意義的領域，它將製劑性能與商業性成果、監管核准和病患體驗緊密聯繫起來。聚合物化學、包覆技術、供應鏈韌性和區域監管要求之間的相互作用決定了包覆策略的可行性和競爭力。對聚合物選擇、製程分析控制和供應商透明度的策略性投資可以顯著降低營運波動，並有助於更順暢的監管流程。

目錄

第1章：序言

第2章調查方法

  • 研究設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查前提
  • 調查限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會地圖
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

8. 依產品類型分類的藥品包衣市場

  • 壓縮塗層
  • 薄膜塗層
  • 聚合物塗層
  • 糖霜

9. 依聚合物類型分類的藥物包衣市場

  • 天然聚合物
    • 明膠
    • 蟲膠
    • 澱粉
  • 合成聚合物
    • 丙烯酸酯
    • 纖維素醚
    • 甲基丙烯酸酯

10. 依給藥途徑分類的藥物包衣市場

  • 口服
  • 腸外
    • 肌肉內注射
    • 靜脈注射
  • 外用

第11章 依應用分類的藥品包衣市場

  • 膠囊
  • 顆粒
  • 顆粒
  • 藥片

第12章 依最終用戶分類的藥品包衣市場

  • 契約製造
  • 醫院和診所
    • 診所
    • 醫院
  • 製藥公司

第13章：依地區分類的藥品包衣市場

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章 藥品包衣市場（依組別分類）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章 各國藥品包衣市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章：美國藥品包衣市場

第17章：中國藥品包衣市場

第18章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • ACG Pharmapack
  • Air Liquide SA
  • Aristocrat Instruments
  • Ashland Global Holdings, Inc.
  • Balchem Corporation
  • BASF SE
  • Biogrund GmbH
  • Biogrund GmbH
  • Coating Place, Inc.
  • Colorcon, Inc.
  • Croda International Plc
  • Eastman Chemical Company
  • Evonik Industries AG
  • FMC Corporation
  • Gattefosse
  • IHSAN Sons（Pvt）Ltd.
  • Kerry Group plc
  • Microchem Srl
  • Pharmachem Laboratories, Inc.
  • Roquette Freres
  • Sensient Technologies Corporation
  • The Dow Chemical Company
  • The Lubrizol Corporation
  • Vikram Thermo（India）Limited
  • Wacker Chemie AG
Product Code: MRR-8D2A80511E8B

The Pharmaceutical Coating Market was valued at USD 4.50 billion in 2025 and is projected to grow to USD 4.81 billion in 2026, with a CAGR of 6.92%, reaching USD 7.19 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 4.50 billion
Estimated Year [2026] USD 4.81 billion
Forecast Year [2032] USD 7.19 billion
CAGR (%) 6.92%

A concise orientation to pharmaceutical coating fundamentals, market drivers, regulatory dynamics, and strategic priorities shaping near-term executive decisions

The pharmaceutical coating sector represents a vital interface between drug formulation science and commercial product delivery, integrating materials science, regulatory compliance, and manufacturing practice. This introduction outlines the domain's core functional roles, emphasizing how coatings modulate stability, bioavailability, patient acceptability, and supply chain robustness. As the industry evolves, coating choices increasingly influence product differentiation and lifecycle strategy; therefore, executives must understand the interplay among formulation components, production constraints, and end-user expectations.

Emerging regulatory scrutiny and heightened quality standards have pushed coating development toward more reproducible, analytically verifiable systems. Consequently, development teams are prioritizing polymer selection, coating process control, and in-line analytical tools to reduce batch variability. At the same time, commercial stakeholders are balancing cost, sustainability, and intellectual property considerations when deciding between in-house formulation versus outsourced coating services. Taken together, these dynamics frame the essential context for subsequent analysis, and set the stage for practical decisions that reconcile scientific objectives with operational realities.

How technological advances, sustainability mandates, and supply chain reconfiguration are driving transformative shifts across pharmaceutical coating formulation and delivery

Technological progress, regulatory emphasis on quality by design, and stakeholder pressure for sustainability are collectively catalyzing transformative shifts across pharmaceutical coating formulation and manufacturing. Advances in polymer chemistry and coating equipment are enabling finer control of film thickness and release profiles, while digital monitoring and process analytical technologies bring previously elusive consistency to large-scale coating operations. At the same time, innovation in functional coatings-such as modified-release and taste-masking systems-expands formulation choices and allows product teams to pursue differentiated delivery profiles with lower risk.

Supply chain realignments and geopolitical considerations are also reshaping strategic priorities. Manufacturers are increasingly evaluating dual-sourcing models, regional manufacturing nodes, and closer integration with polymer suppliers to mitigate disruption risk. Regulatory authorities continue to strengthen expectations around traceability and material characterization, which forces greater transparency upstream in polymer production and downstream in contract manufacture relationships. Sustainability mandates further influence decision-making, encouraging a shift toward biodegradable excipients and solventless coating processes where feasible. In combination, these factors are prompting more cross-functional collaboration among R&D, regulatory affairs, procurement, and commercial teams, thereby accelerating adoption of integrated development practices and smarter sourcing strategies.

Assessing the cumulative operational, pricing, and compliance impacts arising from evolving United States tariff measures and trade policy changes in 2025

Policy shifts and tariff measures instituted by the United States in 2025 introduce tangible pressures on input costs, sourcing choices, and contractual arrangements across the pharmaceutical coating value chain. Rising tariff barriers can increase landed costs for imported polymers and specialty excipients, prompting procurement teams to revisit supplier portfolios, renegotiate terms, and consider nearshoring options. In response, some manufacturers may opt to increase inventory buffers or prioritize long-term supplier contracts to stabilize supply and pricing volatility.

Operational implications extend beyond raw material pricing. Tariff-induced cost escalation can accelerate vertical integration strategies as downstream firms seek to capture more of the value chain and reduce exposure to cross-border duties. Moreover, manufacturing footprints may shift as companies evaluate the trade-offs between higher domestic production costs and the risks associated with international logistics and customs complexity. Regulatory compliance can become more complex when inputs cross additional jurisdictions, increasing documentation burdens and the need for validated supply chain audits.

From a commercial perspective, corporations must weigh the potential for margin compression against strategic opportunities to differentiate through localized supply reliability and faster lead times. Contract manufacturers and service providers face particular pressure to demonstrate resilient sourcing strategies and to offer transparent pass-through cost mechanisms. Ultimately, proactive scenario planning and enhanced supplier collaboration will be critical to managing the cumulative effects of tariff changes while preserving product quality and manufacturing continuity.

Deconstructing segment-level opportunities and performance indicators across product types, polymer chemistries, applications, administration routes, and end-user channels

A granular view of segmentation clarifies how formulation choices, polymer chemistries, and end-user channels intersect with manufacturing and regulatory constraints. Based on Product Type, market is studied across Compression Coating, Film Coating, Polymer Coating, and Sugar Coating, and each product pathway imposes distinct process control and analytical requirements. Compression coating demands precise tablet compaction and layer adhesion control, whereas film coating emphasizes uniformity of polymer dispersion and solvent handling during application. Polymer-based coatings offer functional tunability but require compatibility testing, and sugar coatings present legacy options with particular decorative and taste-masking attributes.

Based on Polymer Type, market is studied across Natural Polymers and Synthetic Polymers. The Natural Polymers is further studied across Gelatin, Shellac, and Starch. The Synthetic Polymers is further studied across Acrylates, Cellulose Ethers, and Methacrylates. Each polymer class carries a different risk profile in terms of batch-to-batch variability, regulatory familiarity, and environmental footprint, which constrains selection in regulated product dossiers. Based on Application, market is studied across Capsules, Granules, Pellets, and Tablets; application form influences coating thickness, adhesion properties, and coating equipment selection, as well as downstream dissolution testing strategies.

Based on Route Of Administration, market is studied across Oral, Parenteral, and Topical. The Parenteral is further studied across Intramuscular and Intravenous. Route of administration drives the highest standards for leachables, extractables, and sterility considerations, particularly when coatings interact with parenteral delivery systems. Based on End User, market is studied across Contract Manufacturers, Hospitals & Clinics, and Pharmaceutical Companies. The Hospitals & Clinics is further studied across Clinics and Hospitals. End users differ in procurement cycles, quality expectations, and tolerance for innovation, which in turn affects commercial strategies and service offerings across the coating ecosystem.

Regional strategic distinctions and demand drivers uncovered across Americas, Europe, Middle East and Africa, and Asia-Pacific markets with operational implications

Regional dynamics exert strong influence on raw material availability, regulatory expectations, and preferred service models. In the Americas, supply chain resilience and regulatory harmonization efforts tend to prioritize compliance documentation, localized quality audits, and a preference for suppliers that can demonstrate rapid response capabilities. This region often drives demand for scalable solutions that align with rapid commercialization timelines and well-established regulatory pathways.

Across Europe, Middle East & Africa, the landscape blends mature regulatory frameworks with diverse market access conditions. The region places premium value on sustainability credentials, solvent reduction, and adherence to rigorous environmental, health, and safety standards. Manufacturers operating here frequently invest in advanced process controls and green formulation approaches to meet both regulatory requirements and stakeholder expectations.

In the Asia-Pacific region, manufacturing scale, supplier diversity, and cost competitiveness coexist with rising expectations for quality assurance and regulatory maturation. Rapidly expanding pharmaceutical production hubs in this region are increasingly adopting sophisticated coating technologies, while contract manufacturing organizations compete on speed and flexibility. Taken together, regional distinctions suggest that a one-size-fits-all strategy will underperform; instead, optimized regional playbooks that align sourcing, compliance, and commercialization will yield superior operational outcomes.

Competitive dynamics, innovation patterns, partnership models, and manufacturing trends shaping company-level strategic positioning in pharmaceutical coatings

Company-level strategies reveal clear patterns of differentiation around innovation, integration, and service specialization. Leading organizations are investing in formulation science, proprietary polymer systems, and automated coating platforms to reduce cycle time and enhance product reproducibility. Others are differentiating through comprehensive service offerings that bundle formulation support, process validation, and supply chain guarantees for contract manufacturing clients.

Strategic partnerships between polymer suppliers, equipment manufacturers, and pharmaceutical developers are emerging as an effective way to accelerate time to market while sharing technical risk. Collaboration models frequently include co-development agreements, technical transfer arrangements, and joint quality assurance programs that align materials characterization with end-use performance. Additionally, firms that articulate clear sustainability roadmaps-such as solvent reduction targets, recyclable packaging, and life cycle analysis-are gaining traction with customers who prioritize environmental metrics alongside technical performance.

Operational excellence remains a critical axis of competition. Companies that standardize process analytical technologies, enforce robust change control, and maintain transparent supplier documentation are better positioned to support complex regulatory filings and to respond to customer demands for traceability. In sum, competitive advantage is increasingly tied to the ability to combine technical differentiation with reliable, auditable supply relationships and value-added services.

Actionable priorities and tactical measures for industry leaders to enhance resilience, accelerate innovation, and optimize sourcing across coating value chains

Industry leaders should take immediate, measurable steps to strengthen resilience, expedite innovation, and optimize sourcing across the coating value chain. First, integrate cross-functional teams that include procurement, regulatory affairs, R&D, and manufacturing early in formulation development to ensure material choices align with operational constraints and approval pathways. This reduces rework and shortens time to market while embedding quality considerations from the outset. Second, diversify sourcing strategies by qualifying alternative suppliers and establishing strategic inventory policies; rigorous supplier audits and material characterization programs will mitigate risk and reduce the probability of supply interruption.

Third, accelerate adoption of process analytical technologies and digital controls to improve reproducibility, lower failure rates, and provide defensible data for regulatory submissions. Fourth, pursue partnerships with polymer innovators and equipment providers to co-develop tailored coating solutions that balance functional performance with sustainability goals. Fifth, build scenario-based financial and operational models that incorporate tariff contingencies, logistics disruptions, and raw material shocks, thereby enabling rapid decision-making under uncertainty. Collectively, these measures create a robust operating posture that preserves product quality, protects margins, and enables strategic agility across changing market and policy environments.

Transparent and replicable research methodology combining primary interviews, technical literature review, regulatory scans, and supply chain validation techniques

The research underpinning this analysis employed a mixed-methods approach that emphasizes transparency, reproducibility, and practical relevance. Primary research included structured interviews and technical consultations with formulation scientists, quality leaders, procurement managers, and contract manufacturing executives to capture real-world constraints and decision criteria. Secondary research encompassed peer-reviewed literature, regulatory guidance documents, material safety data sheets, and equipment technical specifications to validate technical assertions and to contextualize process requirements.

Analytical procedures incorporated thematic synthesis of qualitative inputs, comparative assessment of polymer characteristics, and cross-validation of operational implications with supply chain data. Where appropriate, sensitivity analysis and scenario planning were used to examine the effects of policy shifts and supply disruptions on sourcing decisions and manufacturing resilience. Quality controls included triangulation of findings across independent sources and expert review by industry practitioners to ensure the interpretation of technical data was accurate and actionable. This methodological combination supports robust conclusions that align with both scientific rigor and commercial relevance.

Concise synthesis of strategic implications, emergent risks, and enduring opportunities that should guide executive agendas for pharmaceutical coating programs

In conclusion, pharmaceutical coating is a strategically important discipline that links formulation performance to commercial outcomes, regulatory acceptance, and patient experience. The interplay among polymer chemistry, coating technology, supply chain resilience, and regional regulatory expectations determines the feasibility and competitiveness of coating strategies. Strategic investments in polymer selection, process analytical control, and supplier transparency will materially reduce operational volatility and support smoother regulatory pathways.

Executives must prioritize integrated decision-making that meshes scientific objectives with procurement realities and market access demands. By doing so, organizations can mitigate the impact of external shocks, capture value through innovation, and respond rapidly to evolving customer and regulatory expectations. The synthesis presented here is designed to inform pragmatic action: adopt robust supplier qualification, embrace technological enablers that improve reproducibility, and align formulation choices with long-term sustainability and compliance goals. These measures will help organizations unlock the full potential of coating strategies while maintaining high standards of quality and patient safety.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Pharmaceutical Coating Market, by Product Type

  • 8.1. Compression Coating
  • 8.2. Film Coating
  • 8.3. Polymer Coating
  • 8.4. Sugar Coating

9. Pharmaceutical Coating Market, by Polymer Type

  • 9.1. Natural Polymers
    • 9.1.1. Gelatin
    • 9.1.2. Shellac
    • 9.1.3. Starch
  • 9.2. Synthetic Polymers
    • 9.2.1. Acrylates
    • 9.2.2. Cellulose Ethers
    • 9.2.3. Methacrylates

10. Pharmaceutical Coating Market, by Route Of Administration

  • 10.1. Oral
  • 10.2. Parenteral
    • 10.2.1. Intramuscular
    • 10.2.2. Intravenous
  • 10.3. Topical

11. Pharmaceutical Coating Market, by Application

  • 11.1. Capsules
  • 11.2. Granules
  • 11.3. Pellets
  • 11.4. Tablets

12. Pharmaceutical Coating Market, by End User

  • 12.1. Contract Manufacturers
  • 12.2. Hospitals & Clinics
    • 12.2.1. Clinics
    • 12.2.2. Hospitals
  • 12.3. Pharmaceutical Companies

13. Pharmaceutical Coating Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Pharmaceutical Coating Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Pharmaceutical Coating Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Pharmaceutical Coating Market

17. China Pharmaceutical Coating Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. ACG Pharmapack
  • 18.6. Air Liquide S.A.
  • 18.7. Aristocrat Instruments
  • 18.8. Ashland Global Holdings, Inc.
  • 18.9. Balchem Corporation
  • 18.10. BASF SE
  • 18.11. Biogrund GmbH
  • 18.12. Biogrund GmbH
  • 18.13. Coating Place, Inc.
  • 18.14. Colorcon, Inc.
  • 18.15. Croda International Plc
  • 18.16. Eastman Chemical Company
  • 18.17. Evonik Industries AG
  • 18.18. FMC Corporation
  • 18.19. Gattefosse
  • 18.20. IHSAN Sons (Pvt) Ltd.
  • 18.21. Kerry Group plc
  • 18.22. Microchem Srl
  • 18.23. Pharmachem Laboratories, Inc.
  • 18.24. Roquette Freres
  • 18.25. Sensient Technologies Corporation
  • 18.26. The Dow Chemical Company
  • 18.27. The Lubrizol Corporation
  • 18.28. Vikram Thermo (India) Limited
  • 18.29. Wacker Chemie AG

LIST OF FIGURES

  • FIGURE 1. GLOBAL PHARMACEUTICAL COATING MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL PHARMACEUTICAL COATING MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL PHARMACEUTICAL COATING MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL PHARMACEUTICAL COATING MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL PHARMACEUTICAL COATING MARKET SIZE, BY POLYMER TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL PHARMACEUTICAL COATING MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL PHARMACEUTICAL COATING MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL PHARMACEUTICAL COATING MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL PHARMACEUTICAL COATING MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL PHARMACEUTICAL COATING MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL PHARMACEUTICAL COATING MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES PHARMACEUTICAL COATING MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA PHARMACEUTICAL COATING MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL PHARMACEUTICAL COATING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL PHARMACEUTICAL COATING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL PHARMACEUTICAL COATING MARKET SIZE, BY COMPRESSION COATING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL PHARMACEUTICAL COATING MARKET SIZE, BY COMPRESSION COATING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL PHARMACEUTICAL COATING MARKET SIZE, BY COMPRESSION COATING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL PHARMACEUTICAL COATING MARKET SIZE, BY FILM COATING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL PHARMACEUTICAL COATING MARKET SIZE, BY FILM COATING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL PHARMACEUTICAL COATING MARKET SIZE, BY FILM COATING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL PHARMACEUTICAL COATING MARKET SIZE, BY POLYMER COATING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL PHARMACEUTICAL COATING MARKET SIZE, BY POLYMER COATING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL PHARMACEUTICAL COATING MARKET SIZE, BY POLYMER COATING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL PHARMACEUTICAL COATING MARKET SIZE, BY SUGAR COATING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL PHARMACEUTICAL COATING MARKET SIZE, BY SUGAR COATING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL PHARMACEUTICAL COATING MARKET SIZE, BY SUGAR COATING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL PHARMACEUTICAL COATING MARKET SIZE, BY POLYMER TYPE, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL PHARMACEUTICAL COATING MARKET SIZE, BY NATURAL POLYMERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL PHARMACEUTICAL COATING MARKET SIZE, BY NATURAL POLYMERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL PHARMACEUTICAL COATING MARKET SIZE, BY NATURAL POLYMERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL PHARMACEUTICAL COATING MARKET SIZE, BY NATURAL POLYMERS, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL PHARMACEUTICAL COATING MARKET SIZE, BY GELATIN, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL PHARMACEUTICAL COATING MARKET SIZE, BY GELATIN, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL PHARMACEUTICAL COATING MARKET SIZE, BY GELATIN, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL PHARMACEUTICAL COATING MARKET SIZE, BY SHELLAC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL PHARMACEUTICAL COATING MARKET SIZE, BY SHELLAC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL PHARMACEUTICAL COATING MARKET SIZE, BY SHELLAC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL PHARMACEUTICAL COATING MARKET SIZE, BY STARCH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL PHARMACEUTICAL COATING MARKET SIZE, BY STARCH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL PHARMACEUTICAL COATING MARKET SIZE, BY STARCH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL PHARMACEUTICAL COATING MARKET SIZE, BY SYNTHETIC POLYMERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL PHARMACEUTICAL COATING MARKET SIZE, BY SYNTHETIC POLYMERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL PHARMACEUTICAL COATING MARKET SIZE, BY SYNTHETIC POLYMERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL PHARMACEUTICAL COATING MARKET SIZE, BY SYNTHETIC POLYMERS, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL PHARMACEUTICAL COATING MARKET SIZE, BY ACRYLATES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL PHARMACEUTICAL COATING MARKET SIZE, BY ACRYLATES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL PHARMACEUTICAL COATING MARKET SIZE, BY ACRYLATES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL PHARMACEUTICAL COATING MARKET SIZE, BY CELLULOSE ETHERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL PHARMACEUTICAL COATING MARKET SIZE, BY CELLULOSE ETHERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL PHARMACEUTICAL COATING MARKET SIZE, BY CELLULOSE ETHERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL PHARMACEUTICAL COATING MARKET SIZE, BY METHACRYLATES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL PHARMACEUTICAL COATING MARKET SIZE, BY METHACRYLATES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL PHARMACEUTICAL COATING MARKET SIZE, BY METHACRYLATES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL PHARMACEUTICAL COATING MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL PHARMACEUTICAL COATING MARKET SIZE, BY ORAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL PHARMACEUTICAL COATING MARKET SIZE, BY ORAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL PHARMACEUTICAL COATING MARKET SIZE, BY ORAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL PHARMACEUTICAL COATING MARKET SIZE, BY PARENTERAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL PHARMACEUTICAL COATING MARKET SIZE, BY PARENTERAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL PHARMACEUTICAL COATING MARKET SIZE, BY PARENTERAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL PHARMACEUTICAL COATING MARKET SIZE, BY PARENTERAL, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL PHARMACEUTICAL COATING MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL PHARMACEUTICAL COATING MARKET SIZE, BY INTRAMUSCULAR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL PHARMACEUTICAL COATING MARKET SIZE, BY INTRAMUSCULAR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL PHARMACEUTICAL COATING MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL PHARMACEUTICAL COATING MARKET SIZE, BY INTRAVENOUS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL PHARMACEUTICAL COATING MARKET SIZE, BY INTRAVENOUS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL PHARMACEUTICAL COATING MARKET SIZE, BY TOPICAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL PHARMACEUTICAL COATING MARKET SIZE, BY TOPICAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL PHARMACEUTICAL COATING MARKET SIZE, BY TOPICAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL PHARMACEUTICAL COATING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL PHARMACEUTICAL COATING MARKET SIZE, BY CAPSULES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL PHARMACEUTICAL COATING MARKET SIZE, BY CAPSULES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL PHARMACEUTICAL COATING MARKET SIZE, BY CAPSULES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL PHARMACEUTICAL COATING MARKET SIZE, BY GRANULES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL PHARMACEUTICAL COATING MARKET SIZE, BY GRANULES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL PHARMACEUTICAL COATING MARKET SIZE, BY GRANULES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL PHARMACEUTICAL COATING MARKET SIZE, BY PELLETS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL PHARMACEUTICAL COATING MARKET SIZE, BY PELLETS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL PHARMACEUTICAL COATING MARKET SIZE, BY PELLETS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL PHARMACEUTICAL COATING MARKET SIZE, BY TABLETS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL PHARMACEUTICAL COATING MARKET SIZE, BY TABLETS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL PHARMACEUTICAL COATING MARKET SIZE, BY TABLETS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL PHARMACEUTICAL COATING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL PHARMACEUTICAL COATING MARKET SIZE, BY CONTRACT MANUFACTURERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL PHARMACEUTICAL COATING MARKET SIZE, BY CONTRACT MANUFACTURERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL PHARMACEUTICAL COATING MARKET SIZE, BY CONTRACT MANUFACTURERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL PHARMACEUTICAL COATING MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL PHARMACEUTICAL COATING MARKET SIZE, BY HOSPITALS & CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL PHARMACEUTICAL COATING MARKET SIZE, BY HOSPITALS & CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL PHARMACEUTICAL COATING MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL PHARMACEUTICAL COATING MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL PHARMACEUTICAL COATING MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL PHARMACEUTICAL COATING MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL PHARMACEUTICAL COATING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL PHARMACEUTICAL COATING MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL PHARMACEUTICAL COATING MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL PHARMACEUTICAL COATING MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL PHARMACEUTICAL COATING MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL PHARMACEUTICAL COATING MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL PHARMACEUTICAL COATING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 90. AMERICAS PHARMACEUTICAL COATING MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 91. AMERICAS PHARMACEUTICAL COATING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 92. AMERICAS PHARMACEUTICAL COATING MARKET SIZE, BY POLYMER TYPE, 2018-2032 (USD MILLION)
  • TABLE 93. AMERICAS PHARMACEUTICAL COATING MARKET SIZE, BY NATURAL POLYMERS, 2018-2032 (USD MILLION)
  • TABLE 94. AMERICAS PHARMACEUTICAL COATING MARKET SIZE, BY SYNTHETIC POLYMERS, 2018-2032 (USD MILLION)
  • TABLE 95. AMERICAS PHARMACEUTICAL COATING MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 96. AMERICAS PHARMACEUTICAL COATING MARKET SIZE, BY PARENTERAL, 2018-2032 (USD MILLION)
  • TABLE 97. AMERICAS PHARMACEUTICAL COATING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 98. AMERICAS PHARMACEUTICAL COATING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 99. AMERICAS PHARMACEUTICAL COATING MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
  • TABLE 100. NORTH AMERICA PHARMACEUTICAL COATING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 101. NORTH AMERICA PHARMACEUTICAL COATING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 102. NORTH AMERICA PHARMACEUTICAL COATING MARKET SIZE, BY POLYMER TYPE, 2018-2032 (USD MILLION)
  • TABLE 103. NORTH AMERICA PHARMACEUTICAL COATING MARKET SIZE, BY NATURAL POLYMERS, 2018-2032 (USD MILLION)
  • TABLE 104. NORTH AMERICA PHARMACEUTICAL COATING MARKET SIZE, BY SYNTHETIC POLYMERS, 2018-2032 (USD MILLION)
  • TABLE 105. NORTH AMERICA PHARMACEUTICAL COATING MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 106. NORTH AMERICA PHARMACEUTICAL COATING MARKET SIZE, BY PARENTERAL, 2018-2032 (USD MILLION)
  • TABLE 107. NORTH AMERICA PHARMACEUTICAL COATING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 108. NORTH AMERICA PHARMACEUTICAL COATING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 109. NORTH AMERICA PHARMACEUTICAL COATING MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
  • TABLE 110. LATIN AMERICA PHARMACEUTICAL COATING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 111. LATIN AMERICA PHARMACEUTICAL COATING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 112. LATIN AMERICA PHARMACEUTICAL COATING MARKET SIZE, BY POLYMER TYPE, 2018-2032 (USD MILLION)
  • TABLE 113. LATIN AMERICA PHARMACEUTICAL COATING MARKET SIZE, BY NATURAL POLYMERS, 2018-2032 (USD MILLION)
  • TABLE 114. LATIN AMERICA PHARMACEUTICAL COATING MARKET SIZE, BY SYNTHETIC POLYMERS, 2018-2032 (USD MILLION)
  • TABLE 115. LATIN AMERICA PHARMACEUTICAL COATING MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 116. LATIN AMERICA PHARMACEUTICAL COATING MARKET SIZE, BY PARENTERAL, 2018-2032 (USD MILLION)
  • TABLE 117. LATIN AMERICA PHARMACEUTICAL COATING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 118. LATIN AMERICA PHARMACEUTICAL COATING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 119. LATIN AMERICA PHARMACEUTICAL COATING MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
  • TABLE 120. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL COATING MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 121. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL COATING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 122. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL COATING MARKET SIZE, BY POLYMER TYPE, 2018-2032 (USD MILLION)
  • TABLE 123. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL COATING MARKET SIZE, BY NATURAL POLYMERS, 2018-2032 (USD MILLION)
  • TABLE 124. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL COATING MARKET SIZE, BY SYNTHETIC POLYMERS, 2018-2032 (USD MILLION)
  • TABLE 125. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL COATING MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 126. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL COATING MARKET SIZE, BY PARENTERAL, 2018-2032 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL COATING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 128. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL COATING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 129. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL COATING MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
  • TABLE 130. EUROPE PHARMACEUTICAL COATING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 131. EUROPE PHARMACEUTICAL COATING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 132. EUROPE PHARMACEUTICAL COATING MARKET SIZE, BY POLYMER TYPE, 2018-2032 (USD MILLION)
  • TABLE 133. EUROPE PHARMACEUTICAL COATING MARKET SIZE, BY NATURAL POLYMERS, 2018-2032 (USD MILLION)
  • TABLE 134. EUROPE PHARMACEUTICAL COATING MARKET SIZE, BY SYNTHETIC POLYMERS, 2018-2032 (USD MILLION)
  • TABLE 135. EUROPE PHARMACEUTICAL COATING MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 136. EUROPE PHARMACEUTICAL COATING MARKET SIZE, BY PARENTERAL, 2018-2032 (USD MILLION)
  • TABLE 137. EUROPE PHARMACEUTICAL COATING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 138. EUROPE PHARMACEUTICAL COATING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 139. EUROPE PHARMACEUTICAL COATING MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
  • TABLE 140. MIDDLE EAST PHARMACEUTICAL COATING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 141. MIDDLE EAST PHARMACEUTICAL COATING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 142. MIDDLE EAST PHARMACEUTICAL COATING MARKET SIZE, BY POLYMER TYPE, 2018-2032 (USD MILLION)
  • TABLE 143. MIDDLE EAST PHARMACEUTICAL COATING MARKET SIZE, BY NATURAL POLYMERS, 2018-2032 (USD MILLION)
  • TABLE 144. MIDDLE EAST PHARMACEUTICAL COATING MARKET SIZE, BY SYNTHETIC POLYMERS, 2018-2032 (USD MILLION)
  • TABLE 145. MIDDLE EAST PHARMACEUTICAL COATING MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 146. MIDDLE EAST PHARMACEUTICAL COATING MARKET SIZE, BY PARENTERAL, 2018-2032 (USD MILLION)
  • TABLE 147. MIDDLE EAST PHARMACEUTICAL COATING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 148. MIDDLE EAST PHARMACEUTICAL COATING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 149. MIDDLE EAST PHARMACEUTICAL COATING MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
  • TABLE 150. AFRICA PHARMACEUTICAL COATING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 151. AFRICA PHARMACEUTICAL COATING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 152. AFRICA PHARMACEUTICAL COATING MARKET SIZE, BY POLYMER TYPE, 2018-2032 (USD MILLION)
  • TABLE 153. AFRICA PHARMACEUTICAL COATING MARKET SIZE, BY NATURAL POLYMERS, 2018-2032 (USD MILLION)
  • TABLE 154. AFRICA PHARMACEUTICAL COATING MARKET SIZE, BY SYNTHETIC POLYMERS, 2018-2032 (USD MILLION)
  • TABLE 155. AFRICA PHARMACEUTICAL COATING MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 156. AFRICA PHARMACEUTICAL COATING MARKET SIZE, BY PARENTERAL, 2018-2032 (USD MILLION)
  • TABLE 157. AFRICA PHARMACEUTICAL COATING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 158. AFRICA PHARMACEUTICAL COATING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 159. AFRICA PHARMACEUTICAL COATING MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
  • TABLE 160. ASIA-PACIFIC PHARMACEUTICAL COATING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 161. ASIA-PACIFIC PHARMACEUTICAL COATING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 162. ASIA-PACIFIC PHARMACEUTICAL COATING MARKET SIZE, BY POLYMER TYPE, 2018-2032 (USD MILLION)
  • TABLE 163. ASIA-PACIFIC PHARMACEUTICAL COATING MARKET SIZE, BY NATURAL POLYMERS, 2018-2032 (USD MILLION)
  • TABLE 164. ASIA-PACIFIC PHARMACEUTICAL COATING MARKET SIZE, BY SYNTHETIC POLYMERS, 2018-2032 (USD MILLION)
  • TABLE 165. ASIA-PACIFIC PHARMACEUTICAL COATING MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 166. ASIA-PACIFIC PHARMACEUTICAL COATING MARKET SIZE, BY PARENTERAL, 2018-2032 (USD MILLION)
  • TABLE 167. ASIA-PACIFIC PHARMACEUTICAL COATING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 168. ASIA-PACIFIC PHARMACEUTICAL COATING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 169. ASIA-PACIFIC PHARMACEUTICAL COATING MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
  • TABLE 170. GLOBAL PHARMACEUTICAL COATING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 171. ASEAN PHARMACEUTICAL COATING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 172. ASEAN PHARMACEUTICAL COATING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 173. ASEAN PHARMACEUTICAL COATING MARKET SIZE, BY POLYMER TYPE, 2018-2032 (USD MILLION)
  • TABLE 174. ASEAN PHARMACEUTICAL COATING MARKET SIZE, BY NATURAL POLYMERS, 2018-2032 (USD MILLION)
  • TABLE 175. ASEAN PHARMACEUTICAL COATING MARKET SIZE, BY SYNTHETIC POLYMERS, 2018-2032 (USD MILLION)
  • TABLE 176. ASEAN PHARMACEUTICAL COATING MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 177. ASEAN PHARMACEUTICAL COATING MARKET SIZE, BY PARENTERAL, 2018-2032 (USD MILLION)
  • TABLE 178. ASEAN PHARMACEUTICAL COATING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 179. ASEAN PHARMACEUTICAL COATING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 180. ASEAN PHARMACEUTICAL COATING MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
  • TABLE 181. GCC PHARMACEUTICAL COATING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 182. GCC PHARMACEUTICAL COATING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 183. GCC PHARMACEUTICAL COATING MARKET SIZE, BY POLYMER TYPE, 2018-2032 (USD MILLION)
  • TABLE 184. GCC PHARMACEUTICAL COATING MARKET SIZE, BY NATURAL POLYMERS, 2018-2032 (USD MILLION)
  • TABLE 185. GCC PHARMACEUTICAL COATING MARKET SIZE, BY SYNTHETIC POLYMERS, 2018-2032 (USD MILLION)
  • TABLE 186. GCC PHARMACEUTICAL COATING MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 187. GCC PHARMACEUTICAL COATING MARKET SIZE, BY PARENTERAL, 2018-2032 (USD MILLION)
  • TABLE 188. GCC PHARMACEUTICAL COATING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 189. GCC PHARMACEUTICAL COATING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 190. GCC PHARMACEUTICAL COATING MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
  • TABLE 191. EUROPEAN UNION PHARMACEUTICAL COATING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 192. EUROPEAN UNION PHARMACEUTICAL COATING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 193. EUROPEAN UNION PHARMACEUTICAL COATING MARKET SIZE, BY POLYMER TYPE, 2018-2032 (USD MILLION)
  • TABLE 194. EUROPEAN UNION PHARMACEUTICAL COATING MARKET SIZE, BY NATURAL POLYMERS, 2018-2032 (USD MILLION)
  • TABLE 195. EUROPEAN UNION PHARMACEUTICAL COATING MARKET SIZE, BY SYNTHETIC POLYMERS, 2018-2032 (USD MILLION)
  • TABLE 196. EUROPEAN UNION PHARMACEUTICAL COATING MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 197. EUROPEAN UNION PHARMACEUTICAL COATING MARKET SIZE, BY PARENTERAL, 2018-2032 (USD MILLION)
  • TABLE 198. EUROPEAN UNION PHARMACEUTICAL COATING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 199. EUROPEAN UNION PHARMACEUTICAL COATING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 200. EUROPEAN UNION PHARMACEUTICAL COATING MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
  • TABLE 201. BRICS PHARMACEUTICAL COATING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 202. BRICS PHARMACEUTICAL COATING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 203. BRICS PHARMACEUTICAL COATING MARKET SIZE, BY POLYMER TYPE, 2018-2032 (USD MILLION)
  • TABLE 204. BRICS PHARMACEUTICAL COATING MARKET SIZE, BY NATURAL POLYMERS, 2018-2032 (USD MILLION)
  • TABLE 205. BRICS PHARMACEUTICAL COATING MARKET SIZE, BY SYNTHETIC POLYMERS, 2018-2032 (USD MILLION)
  • TABLE 206. BRICS PHARMACEUTICAL COATING MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 207. BRICS PHARMACEUTICAL COATING MARKET SIZE, BY PARENTERAL, 2018-2032 (USD MILLION)
  • TABLE 208. BRICS PHARMACEUTICAL COATING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 209. BRICS PHARMACEUTICAL COATING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 210. BRICS PHARMACEUTICAL COATING MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
  • TABLE 211. G7 PHARMACEUTICAL COATING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 212. G7 PHARMACEUTICAL COATING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 213. G7 PHARMACEUTICAL COATING MARKET SIZE, BY POLYMER TYPE, 2018-2032 (USD MILLION)
  • TABLE 214. G7 PHARMACEUTICAL COATING MARKET SIZE, BY NATURAL POLYMERS, 2018-2032 (USD MILLION)
  • TABLE 215. G7 PHARMACEUTICAL COATING MARKET SIZE, BY SYNTHETIC POLYMERS, 2018-2032 (USD MILLION)
  • TABLE 216. G7 PHARMACEUTICAL COATING MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 217. G7 PHARMACEUTICAL COATING MARKET SIZE, BY PARENTERAL, 2018-2032 (USD MILLION)
  • TABLE 218. G7 PHARMACEUTICAL COATING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 219. G7 PHARMACEUTICAL COATING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 220. G7 PHARMACEUTICAL COATING MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
  • TABLE 221. NATO PHARMACEUTICAL COATING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 222. NATO PHARMACEUTICAL COATING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 223. NATO PHARMACEUTICAL COATING MARKET SIZE, BY POLYMER TYPE, 2018-2032 (USD MILLION)
  • TABLE 224. NATO PHARMACEUTICAL COATING MARKET SIZE, BY NATURAL POLYMERS, 2018-2032 (USD MILLION)
  • TABLE 225. NATO PHARMACEUTICAL COATING MARKET SIZE, BY SYNTHETIC POLYMERS, 2018-2032 (USD MILLION)
  • TABLE 226. NATO PHARMACEUTICAL COATING MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 227. NATO PHARMACEUTICAL COATING MARKET SIZE, BY PARENTERAL, 2018-2032 (USD MILLION)
  • TABLE 228. NATO PHARMACEUTICAL COATING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 229. NATO PHARMACEUTICAL COATING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 230. NATO PHARMACEUTICAL COATING MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
  • TABLE 231. GLOBAL PHARMACEUTICAL COATING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 232. UNITED STATES PHARMACEUTICAL COATING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 233. UNITED STATES PHARMACEUTICAL COATING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 234. UNITED STATES PHARMACEUTICAL COATING MARKET SIZE, BY POLYMER TYPE, 2018-2032 (USD MILLION)
  • TABLE 235. UNITED STATES PHARMACEUTICAL COATING MARKET SIZE, BY NATURAL POLYMERS, 2018-2032 (USD MILLION)
  • TABLE 236. UNITED STATES PHARMACEUTICAL COATING MARKET SIZE, BY SYNTHETIC POLYMERS, 2018-2032 (USD MILLION)
  • TABLE 237. UNITED STATES PHARMACEUTICAL COATING MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 238. UNITED STATES PHARMACEUTICAL COATING MARKET SIZE, BY PARENTERAL, 2018-2032 (USD MILLION)
  • TABLE 239. UNITED STATES PHARMACEUTICAL COATING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 240. UNITED STATES PHARMACEUTICAL COATING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 241. UNITED STATES PHARMACEUTICAL COATING MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
  • TABLE 242. CHINA PHARMACEUTICAL COATING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 243. CHINA PHARMACEUTICAL COATING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 244. CHINA PHARMACEUTICAL COATING MARKET SIZE, BY POLYMER TYPE, 2018-2032 (USD MILLION)
  • TABLE 245. CHINA PHARMACEUTICAL COATING MARKET SIZE, BY NATURAL POLYMERS, 2018-2032 (USD MILLION)
  • TABLE 246. CHINA PHARMACEUTICAL COATING MARKET SIZE, BY SYNTHETIC POLYMERS, 2018-2032 (USD MILLION)
  • TABLE 247. CHINA PHARMACEUTICAL COATING MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 248. CHINA PHARMACEUTICAL COATING MARKET SIZE, BY PARENTERAL, 2018-2032 (USD MILLION)
  • TABLE 249. CHINA PHARMACEUTICAL COATING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 250. CHINA PHARMACEUTICAL COATING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 251. CHINA PHARMACEUTICAL COATING MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)